Skip to main content
SpringerLink
Log in

Urinary Tract Infections Among Patients with Neurogenic Bladder

  • Reference work entry
  • First Online:
Handbook of Neurourology

  • 432 Accesses

Abstract

Urinary tract infections (UTIs) in patients with neurogenic bladder (NB) are a major public health issue due to their high incidence and major consequences. They are associated with high morbidity and healthcare utilization, with a major economic burden. Their physiopathology, especially immunological and neurological function, is poorly understood.

Some risk factors for UTI among patients with neurological bladder have been established: indwelling catheter, urinary stasis, high bladder pressure, bladder stones, etc.

Their diagnosis is a major challenge as clinical signs are often nonspecific and poor. Microbiological data are of limited help and varied flora could be involved.

A urinary sample should be analyzed in appropriate conditions before any antibiotic prescription. According to most guidelines, a bacterial threshold ≥103 CFU/mL associated with symptoms is acceptable to define UTI among NB population.

The management of acute, symptomatic UTI is not evidence based. A management with a single agent and a short antibiotic treatment of 10 days or less seems as effective as 15 or 21 days.

Antibiotic selection should be based on patient-based resistance patterns, and the spectrum should be as narrow as possible. Bacteriophages could be an alternative in the future.

Asymptomatic bacteriuria (ABU) should not be treated, to avoid the emergence of bacterial resistance.

Regarding preventive measures, use of clean intermittent catheterization (CIC), intravesical botulinum toxin injection, and cycling antibiotic prevention are effective. Bacterial interference is promising, but randomized controlled trials are needed.

Here is provided a review of data available on neurogenic bladder UTI.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. M.S. Jahromi, A. Mure, C.S. Gomez, UTIs in patients with neurogenic bladder. Curr. Urol. Rep. 15, 433 (2014)

    Article  PubMed  Google Scholar 

  2. M.E. Garcia Leoni, A. Esclarin De Ruz, Management of urinary tract infection in patients with spinal cord injuries. Clin. Microbiol. Infect. 9, 780–785 (2003)

    Article  CAS  PubMed  Google Scholar 

  3. A. Manack, S.P. Motsko, C. Haag-Molkenteller, et al., Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol. Urodyn. 30, 395–401 (2011). https://doi.org/10.1002/nau.21003

    Article  PubMed  Google Scholar 

  4. C. Jia, L.-M. Liao, G. Chen, Y. Sui, Detrusor botulinum toxin a injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 51, 487–490 (2013). https://doi.org/10.1038/sc.2012.180

    Article  CAS  PubMed  Google Scholar 

  5. F. D’Hondt, K. Everaert, Urinary tract infections in patients with spinal cord injuries. Curr. Infect. Dis. Rep. 13, 544–551 (2011). https://doi.org/10.1007/s11908-011-0208-6

    Article  PubMed  Google Scholar 

  6. Haute Autorité de Santé (2007) Guide Affection Longue Durée - Paraplégie (lésions médullaires)

    Google Scholar 

  7. G. Dow, P. Rao, G. Harding, et al., A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin. Infect. Dis. 39, 658–664 (2004)

    Article  CAS  PubMed  Google Scholar 

  8. D.D. Cardenas, T.M. Hooton, Urinary tract infection in persons with spinal cord injury. Arch. Phys. Med. Rehabil. 76, 272–280 (1995)

    Article  CAS  PubMed  Google Scholar 

  9. Nicolle LE, Bradley S, Colgan R, et al (2005) Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin. Infect. Dis. 40:643–654. https://doi.org/10.1086/427507

  10. K.J. Weld, R.R. Dmochowski, Effect of bladder management on urological complications in spinal cord injured patients. J. Urol. 163, 768–772 (2000)

    Article  CAS  PubMed  Google Scholar 

  11. M.B. Siroky, Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am. J. Med. 113(Suppl), 67S–79S (2002)

    Article  PubMed  Google Scholar 

  12. E.J. McGuire, J.A. Savastano, Long-term follow-up of spinal cord injury patients managed by intermittent catheterization. J. Urol. 129, 775–776 (1983)

    Article  CAS  PubMed  Google Scholar 

  13. G. DeJong, W. Tian, C.-H. Hsieh, et al., Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch. Phys. Med. Rehabil. 94, S87–S97 (2013). https://doi.org/10.1016/j.apmr.2012.10.037

    Article  PubMed  Google Scholar 

  14. H.-H.S. Wang, J.S. Wiener, S.S. Ross, J.C. Routh, Emergent care patterns in patients with Spina bifida: A case-control study. J. Urol. 193, 268–273 (2015). https://doi.org/10.1016/j.juro.2014.06.085

    Article  PubMed  Google Scholar 

  15. S.J.T. Guilcher, B.C. Craven, A. Calzavara, et al., Is the emergency department an appropriate substitute for primary care for persons with traumatic spinal cord injury? Spinal Cord 51, 202–208 (2013). https://doi.org/10.1038/sc.2012.123

    Article  CAS  PubMed  Google Scholar 

  16. S. Unsal-Delialioglu, K. Kaya, S. Sahin-Onat, et al., Fever during rehabilitation in patients with traumatic spinal cord injury: Analysis of 392 cases from a national rehabilitation hospital in Turkey. J. Spinal Cord Med. 33, 243–248 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  17. R.W. Haley, D.H. Culver, J.W. White, et al., The nationwide nosocomial infection rate. A new need for vital statistics. Am. J. Epidemiol. 121, 159–167 (1985)

    Article  CAS  PubMed  Google Scholar 

  18. R. Platt, B.F. Polk, B. Murdock, B. Rosner, Mortality associated with nosocomial urinary-tract infection. N. Engl. J. Med. 307, 637–642 (1982). https://doi.org/10.1056/NEJM198209093071101

    Article  CAS  PubMed  Google Scholar 

  19. R. Chaudhry, R.J. Madden-Fuentes, T.K. Ortiz, et al., Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J. Urol. 191, 1454–1461 (2014). https://doi.org/10.1016/j.juro.2013.12.013

    Article  PubMed  Google Scholar 

  20. M.H. Rabadi, S.K. Mayanna, A.S. Vincent, Predictors of mortality in veterans with traumatic spinal cord injury. Spinal Cord 5177, 784–788 (2013). https://doi.org/10.1038/sc.2013.77

    Article  Google Scholar 

  21. T. Togan, O.K. Azap, E. Durukan, H. Arslan, The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J. Microbiol. 7, e8905 (2014). https://doi.org/10.5812/jjm.8905

    Article  PubMed  PubMed Central  Google Scholar 

  22. S.B. Yoon, B.S. Lee, K.D. Lee, et al., Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord 52, 298–301 (2014). https://doi.org/10.1038/sc.2014.10

    Article  CAS  PubMed  Google Scholar 

  23. C.F. Martins, E. Bronzatto, J.M. Neto, et al., Urinary tract infection analysis in a spinal cord injured population undergoing rehabilitation—How to treat? Spinal Cord 51, 193–195 (2013). https://doi.org/10.1038/sc.2012.104

    Article  CAS  PubMed  Google Scholar 

  24. A. Esclarín De Ruz, E. García Leoni, R. Herruzo Cabrera, Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J. Urol. 164, 1285–1289 (2000)

    Article  PubMed  Google Scholar 

  25. F. Biering-Sørensen, P. Bagi, N. Høiby, Urinary tract infections in patients with spinal cord lesions: Treatment and prevention. Drugs 61, 1275–1287 (2001)

    Article  PubMed  Google Scholar 

  26. D. Guillemot, C. Carbon, B. Balkau, et al., Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279, 365–370 (1998)

    Article  CAS  PubMed  Google Scholar 

  27. A. Hinkel, W. Finke, U. Bötel, et al., Increasing resistance against antibiotics in bacteria isolated from the lower urinary tract of an outpatient population of spinal cord injury patients. Urol. Int. 73, 143–148 (2004). https://doi.org/10.1159/000079695

    Article  CAS  PubMed  Google Scholar 

  28. M.-C. Roghmann, M.T. Wallin, P.H. Gorman, J.A. Johnson, Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Arch. Phys. Med. Rehabil. 87, 1305–1309 (2006). https://doi.org/10.1016/j.apmr.2006.07.260

    Article  PubMed  Google Scholar 

  29. K.B. Waites, Y. Chen, M.J. DeVivo, et al., Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury. Arch. Phys. Med. Rehabil. 81, 764–769 (2000)

    Article  CAS  PubMed  Google Scholar 

  30. A. Dinh, M. Saliba, D. Saadeh, et al., Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: A comparative study. Spinal Cord (2016)

    Google Scholar 

  31. C.T. Evans, T.J. Rogers, A. Chin, et al., Antibiotic prescribing trends in the emergency department for veterans with spinal cord injury and disorder 2002-2007. J. Spinal Cord Med. 36, 492–498 (2013). https://doi.org/10.1179/2045772312Y.0000000076

    Article  PubMed  PubMed Central  Google Scholar 

  32. A.L. Flores-Mireles, J.N. Walker, M. Caparon, S.J. Hultgren, Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269–284 (2015). https://doi.org/10.1038/nrmicro3432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. P. Vasudeva, H. Madersbacher, Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: Some revered, few forgotten, others ignored. Neurourol. Urodyn. 33, 95–100 (2014). https://doi.org/10.1002/nau.22378

    Article  PubMed  Google Scholar 

  34. X. Gamé, E. Castel-Lacanal, Y. Bentaleb, et al., Botulinum toxin a detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur. Urol. 53, 613–619 (2008). https://doi.org/10.1016/j.eururo.2007.08.039

    Article  PubMed  Google Scholar 

  35. J.L. Merritt, Residual urine volume: Correlate of urinary tract infection in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 62, 558–561 (1981)

    CAS  PubMed  Google Scholar 

  36. D.E. Neal, Host defense mechanisms in urinary tract infections. Urol. Clin. North Am. 26, 677–686 (1999)., vii

    Article  PubMed  Google Scholar 

  37. C.L. Parsons, C. Greenspan, S.W. Moore, S.G. Mulholland, Role of surface mucin in primary antibacterial defense of bladder. Urology 9, 48–52 (1977)

    Article  CAS  PubMed  Google Scholar 

  38. C.L. Parsons, S.H. Shrom, P.M. Hanno, S.G. Mulholland, Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect. Investig. Urol. 16, 196–200 (1978)

    CAS  Google Scholar 

  39. A.E. Wold, J. Mestecky, M. Tomana, et al., Secretory immunoglobulin a carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58, 3073–3077 (1990)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Vaidyanathan S, McDicken IW, Soni BM, et al (2000) Secretory immunoglobulin A in the vesical urothelium of patients with neuropathic bladder--an immunohistochemical study. Spinal Cord 38:378–381

    Google Scholar 

  41. T.A. Schlager, R. Grady, S.E. Mills, J.O. Hendley, Bladder epithelium is abnormal in patients with neurogenic bladder due to myelomeningocele. Spinal Cord 42, 163–168 (2004). https://doi.org/10.1038/sj.sc.3101565

    Article  CAS  PubMed  Google Scholar 

  42. S. Vaidyanathan, I.W. McDicken, A.J. Ikin, et al., A study of cytokeratin 20 immunostaining in the urothelium of neuropathic bladder of patients with spinal cord injury. BMC Urol. 2, 7 (2002)

    Article  PubMed  PubMed Central  Google Scholar 

  43. Z.R. Balsara, S.S. Ross, P.C. Dolber, et al., Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder. Infect. Immun. 81, 3018–3026 (2013). https://doi.org/10.1128/IAI.00255-13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. T.M. Hooton, S.F. Bradley, D.D. Cardenas, et al., Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America (IDSA). Clin. Infect. Dis. 50, 625–663 (2010)

    Article  PubMed  Google Scholar 

  45. P.A. Tambyah, K.T. Halvorson, D.G. Maki, A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin. Proc. 74, 131–136 (1999). https://doi.org/10.4065/74.2.131

    Article  CAS  PubMed  Google Scholar 

  46. R. Ikäheimo, A. Siitonen, U. Kärkkäinen, P.H. Mäkelä, Virulence characteristics of Escherichia coli in nosocomial urinary tract infection. Clin. Infect. Dis. 16, 785–791 (1993)

    Article  PubMed  Google Scholar 

  47. J.R. Johnson, Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect. Dis. Clin. N. Am. 17, 261–278 (2003)., viii

    Article  Google Scholar 

  48. S.M. Jacobsen, D.J. Stickler, H.L.T. Mobley, M.E. Shirtliff, Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21, 26–59 (2008). https://doi.org/10.1128/CMR.00019-07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. W.E. Stamm, Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and prevention. Am. J. Med. 91, 65S–71S (1991)

    Article  CAS  PubMed  Google Scholar 

  50. S. Saint, C.E. Chenoweth, Biofilms and catheter-associated urinary tract infections. Infect. Dis. Clin. N. Am. 17, 411–432 (2003)

    Article  Google Scholar 

  51. D.E. Fouts, R. Pieper, S. Szpakowski, et al., Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J. Transl. Med. 10, 174 (2012). https://doi.org/10.1186/1479-5876-10-174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. W.C. De Groat, I. Araki, M.A. Vizzard, et al., Developmental and injury induced plasticity in the micturition reflex pathway. Behav. Brain Res. 92, 127–140 (1998). https://doi.org/10.1016/S0166-4328(97)00185-X

    Article  PubMed  Google Scholar 

  53. A. Kanai, I. Zabbarova, Y. Ikeda, et al., Sophisticated models and methods for studying neurogenic bladder dysfunction. Neurourol. Urodyn. 30, 658–667 (2011). https://doi.org/10.1002/nau.21120

    Article  PubMed  PubMed Central  Google Scholar 

  54. M. Yoshiyama, F.M. Nezu, O. Yokoyama, et al., Changes in micturition after spinal cord injury in conscious rats. Urology 54, 929–933 (1999). https://doi.org/10.1016/S0090-4295(99)00234-4

    Article  CAS  PubMed  Google Scholar 

  55. V. Jayawardena, M. Midha, Significance of bacteriuria in neurogenic bladder. J. Spinal Cord Med. 27, 102–105 (2004)

    Article  PubMed  Google Scholar 

  56. T.M. Hooton, P.L. Roberts, M.E. Cox, A.E. Stapleton, Voided midstream urine culture and acute cystitis in premenopausal women. N. Engl. J. Med. 369, 1883–1891 (2013). https://doi.org/10.1056/NEJMoa1302186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. National Institute on Disability and Rehabilitation Research, The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research consensus statement. January 27–29, 1992. J. Am. Paraplegia Soc. 15, 194–204 (1992)

    Google Scholar 

  58. A.P. Cameron, G.M. Rodriguez, K.G. Schomer, Systematic review of urological followup after spinal cord injury. J. Urol. 187, 391–397 (2012). https://doi.org/10.1016/j.juro.2011.10.020

    Article  PubMed  Google Scholar 

  59. L.L. Goetz, D.D. Cardenas, M. Kennelly, et al., International spinal cord injury urinary tract infection basic data set. Spinal Cord 51, 700–704 (2013). https://doi.org/10.1038/sc.2013.72

    Article  CAS  PubMed  Google Scholar 

  60. L.M. Massa, J.M. Hoffman, D.D. Cardenas, Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J. Spinal Cord Med. 32, 568–573 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  61. T.A. Linsenmeyer, A. Oakley, Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J. Spinal Cord Med. 26, 352–357 (2003)

    Article  PubMed  Google Scholar 

  62. E. Ronco, P. Denys, C. Bernede-Bauduin, et al., Diagnostic criteria of urinary tract infection in male patients with spinal cord injury. Neurorehabil. Neural Repair 25, 351–358 (2011). https://doi.org/10.1177/1545968310383432

    Article  PubMed  Google Scholar 

  63. W.S. El Masri, S. Patil, K.V. Prasanna, J.R. Chowdhury, To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question! Spinal Cord 52, 49–53 (2014). https://doi.org/10.1038/sc.2013.119

    Article  Google Scholar 

  64. A. Salameh, M.A. Mohajer, R.O. Darouiche, Prevention of urinary tract infections in patients with spinal cord injury. Can. Med. Assoc. J. 187, 807–811 (2015). https://doi.org/10.1503/cmaj.141044

    Article  Google Scholar 

  65. GROUPE DE TRAVAIL

    Google Scholar 

  66. A.G. Pinson, J.T. Philbrick, G.H. Lindbeck, J.B. Schorling, Fever in the clinical diagnosis of acute pyelonephritis. Am. J. Emerg. Med. 15, 148–151 (1997)

    Article  CAS  PubMed  Google Scholar 

  67. D.J. Shea, Pyelonephritis and female urinary tract infection. Emerg. Med. Clin. North Am. 6, 403–417 (1988)

    Article  CAS  PubMed  Google Scholar 

  68. J.R. Johnson, W.E. Stamm, Diagnosis and treatment of acute urinary tract infections. Infect. Dis. Clin. N. Am. 1, 773–791 (1987)

    Article  CAS  Google Scholar 

  69. E. Rubinstein, Short antibiotic treatment courses or how short is short? Int. J. Antimicrob. Agents 30(Suppl.1), 76–79 (2007)

    Article  Google Scholar 

  70. T. Sandberg, G. Skoog, A.B. Hermansson, et al., Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: A randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 380, 484–490 (2012)

    Article  CAS  PubMed  Google Scholar 

  71. R.O. Darouiche, M. Al Mohajer, D.M. Siddiq, C.G. Minard, Short versus long course of antibiotics for catheter-associated urinary tract infections in patients with spinal cord injury: A randomized controlled noninferiority trial. Arch. Phys. Med. Rehabil. 95, 290–296 (2014). https://doi.org/10.1016/j.apmr.2013.09.003

    Article  PubMed  Google Scholar 

  72. A. Dinh, A. Toumi, C. Blanc, et al., Management of febrile urinary tract infection among spinal cord injured patients. BMC Infect. Dis. 16, 156 (2016). https://doi.org/10.1186/s12879-016-1484-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. M. Saliba, D. Saadeh, F. Bouchand, et al., Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms. Spinal Cord 55, 148–154 (2017). https://doi.org/10.1038/sc.2016.176

    Article  CAS  PubMed  Google Scholar 

  74. J.Z. Montgomerie, Infections in patients with spinal cord injuries. Clin. Infect. Dis. 25, 1285–1290 (1997) –2

    Article  CAS  PubMed  Google Scholar 

  75. J.Z. Montgomerie, E. Chan, D.S. Gilmore, et al., Low mortality among patients with spinal cord injury and bacteremia. Rev. Infect. Dis. 13, 867–871

    Google Scholar 

  76. K. Bhatt, E. Cid, D. Maiman, Bacteremia in the spinal cord injury population. J. Am. Paraplegia Soc. 10, 11–14

    Google Scholar 

  77. A.S. Michalopoulos, I.G. Livaditis, V. Gougoutas, The revival of fosfomycin. Int. J. Infect. Dis. 15, e732–e739 (2011). https://doi.org/10.1016/j.ijid.2011.07.007

    Article  CAS  PubMed  Google Scholar 

  78. Y. Cai, Y. Fan, R. Wang, et al., Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. J. Antimicrob. Chemother. 64, 563–566 (2009). https://doi.org/10.1093/jac/dkp224

    Article  CAS  PubMed  Google Scholar 

  79. J.M. Rodríguez-Martínez, S. Ballesta, Á. Pascual, Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int. J. Antimicrob. Agents 30, 366–368 (2007). https://doi.org/10.1016/j.ijantimicag.2007.05.005

    Article  CAS  PubMed  Google Scholar 

  80. M.E. Falagas, A.C. Kastoris, D.E. Karageorgopoulos, P.I. Rafailidis, Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting gram-negative bacilli: A systematic review of microbiological, animal and clinical studies. Int. J. Antimicrob. Agents 34, 111–120 (2009). https://doi.org/10.1016/j.ijantimicag.2009.03.009

    Article  CAS  PubMed  Google Scholar 

  81. S. Jacobson, L. Junco Noa, S. Ahmed, M.R. Wallace, Efficacy and safety of oral fosfomycin for urinary tract infections in hospitalized patients. Antimicrob. Agents Chemother. 60, 1952–1952 (2016). https://doi.org/10.1128/AAC.02971-15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. T. Cai, S. Mazzoli, N. Mondaini, et al., The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: To treat or not to treat? Clin. Infect. Dis. 55, 771–777 (2012). https://doi.org/10.1093/cid/cis534

    Article  PubMed  Google Scholar 

  83. J. Salomon, P. Denys, C. Merle, et al., Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study. J. Antimicrob. Chemother. 57, 784–788 (2006). https://doi.org/10.1093/jac/dkl010

    Article  CAS  PubMed  Google Scholar 

  84. C. Poirier, A. Dinh, J. Salomon, et al., Antibiotic cycling prevents urinary tract infections in spinal cord injury patients and limits the emergence of multidrug resistant organism. J. Infect. 71, 491–493 (2015). https://doi.org/10.1016/j.jinf.2015.06.001

    Article  PubMed  Google Scholar 

  85. R.O. Darouiche, B.G. Green, W.H. Donovan, et al., Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 78, 341–346 (2011). https://doi.org/10.1016/j.urology.2011.03.062

    Article  PubMed  Google Scholar 

  86. B.W. Trautner, R.A. Hull, J.I. Thornby, R.O. Darouiche, Coating urinary catheters with an Avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect. Control Hosp. Epidemiol. 28, 92–94 (2007). https://doi.org/10.1086/510872

    Article  PubMed  Google Scholar 

  87. R.O. Darouiche, W.H. Donovan, M. Del Terzo, et al., Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58, 339–344 (2001)

    Article  CAS  PubMed  Google Scholar 

  88. F. Sundén, L. Håkansson, E. Ljunggren, B. Wullt, Bacterial interference—Is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection? Int. J. Antimicrob. Agents 28, 26–29 (2006). https://doi.org/10.1016/j.ijantimicag.2006.05.007

    Article  CAS  Google Scholar 

  89. R.O. Darouiche, J.I. Thornby, C.C. Stewart, et al., Bacterial interference for prevention of urinary tract infection: A prospective, randomized, placebo-controlled, double-blind pilot trial. Clin. Infect. Dis. 41, 1531–1534 (2005). https://doi.org/10.1086/497272

    Article  PubMed  Google Scholar 

  90. D. Horwitz, T. McCue, A.C. Mapes, et al., Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. J. Infect. 71, 358–367 (2015). https://doi.org/10.1016/j.jinf.2015.05.014

    Article  PubMed  PubMed Central  Google Scholar 

  91. T.A. Linsenmeyer, B. Harrison, A. Oakley, et al., Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. A prospective, double-blinded, placebo-controlled, crossover study. J. Spinal Cord Med. 27, 29–34 (2004)

    Article  PubMed  Google Scholar 

  92. M.F. Lorenzo-Gómez, B. Padilla-Fernández, F.J. García-Criado, et al., Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics. Int. Urogynecol. J. 24, 127–134 (2013). https://doi.org/10.1007/s00192-012-1853-5

    Article  PubMed  Google Scholar 

  93. J.-P. Lavigne, X. Vitrac, L. Bernard, et al., Propolis can potentialise the anti-adhesion activity of proanthocyanidins on uropathogenic Escherichia coli in the prevention of recurrent urinary tract infections. BMC. Res. Notes 4, 522 (2011). https://doi.org/10.1186/1756-0500-4-522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. K.S. Kim, J.-Y. Kim, I.G. Jeong, et al., A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis. J. Korean Med. Sci. 25, 435–439 (2010). https://doi.org/10.3346/jkms.2010.25.3.435

    Article  PubMed  PubMed Central  Google Scholar 

  95. H.W. Bauer, S. Alloussi, G. Egger, et al., A long-term, Multicenter, double-blind study of an Escherichia Coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur. Urol. 47, 542–548 (2005). https://doi.org/10.1016/j.eururo.2004.12.009

    Article  PubMed  Google Scholar 

  96. K.-D. Sievert, B. Amend, G. Gakis, et al., Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann. Neurol. 67, 74–84 (2010). https://doi.org/10.1002/ana.21814

    Article  PubMed  Google Scholar 

  97. (2007) GUIDE -AFFECTION DE LONGUE DURÉE PARAPLÉGIE (lésions médullaires)

    Google Scholar 

  98. Martin C, Auboyer C, Dupont H, et al Antibioprophylaxie en chirurgie et médecine interventionnelle. (patients adultes) Actualisation 2010 Comité de pilotage Société française d’anesthésie et de réanimation Avec la collaboration des sociétés savantes suivantes

    Google Scholar 

  99. F. Bruyère, A. Sotto, L. Escaravage, et al., Recommendations of the infectious disease Committee of the French Association of Urology (AFU): Antibiotic prophylaxis for urological procedures. Prog. Urol. 20, 101–108 (2010). https://doi.org/10.1016/j.purol.2009.11.003

    Article  PubMed  Google Scholar 

  100. L.L. Furfaro, M.S. Payne, B.J. Chang, Bacteriophage therapy: Clinical trials and regulatory hurdles. Front. Cell. Infect. Microbiol. 8, 376 (2018). https://doi.org/10.3389/fcimb.2018.00376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. L. Leitner, W. Sybesma, N. Chanishvili, M. Goderdzishvili, A. Chkhotua, A. Ujmajuridze, M.P. Schneider, A. Sartori, U. Mehnert, L.M. Bachmann, T.M. Kessler, Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomized, placebo-controlled, double-blind clinical trial. BMC Urol. 17(1), 90 (2017). https://doi.org/10.1186/s12894-017-0283-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Diseases Unit, Raymond Poincaré University Hospital, APHP, Versailles Saint Quentin University, Garches, France

    Aurélien Dinh & Jérôme Salomon

  2. Neuro-urology Unit, Raymond Poincaré University Hospital, APHP, Versailles Saint Quentin University, Garches, France

    Pierre Denys

Authors
  1. Aurélien Dinh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérôme Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre Denys
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aurélien Dinh .

Editor information

Editors and Affiliations

  1. Department of Urology Department of Neurourology, China Rehabiliation Research Center China Rehabilitation Science InstituteCapital Medical University, Beijing, China

    Limin Liao

  2. Department of Urology, Medical University Innsbruck, University Hospital, Innsbruck, Austria

    Helmut Madersbacher

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Dinh, A., Salomon, J., Denys, P. (2023). Urinary Tract Infections Among Patients with Neurogenic Bladder. In: Liao, L., Madersbacher, H. (eds) Handbook of Neurourology. Springer, Singapore. https://doi.org/10.1007/978-981-99-1659-7_51

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1659-7_51

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1658-0

  • Online ISBN: 978-981-99-1659-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation